Investor’s Advantage Corp Founder and President John Grace joins Yahoo Finance’s Seana Smith to discuss the market outlook as investors weigh reopening concerns....
Gold is trading between a pair of 50% levels at $1682.40 and $1727.50 for the 11th straight session. This tends to indicate investor indecision and impending volatility....
Bluebird bio Inc. (BLUE) said on Monday its partner Bristol Myers Squibb Co. (BMY) will pay $200 million to buy out future royalty obligations of its two jointly developed cancer therapies.Under the terms of an amended agreement, Bristol Myers will pay Bluebird bio to buy out future royalty obligations on outside of the U.S. sales for its two treatments, ide-cel and bb21217, which belong to a group of drugs called CAR T immunotherapy.“Our collaboration with Bluebird has resulted in the first CAR T cell therapy submitted for regulatory approval to target the B-cell maturation antigen and for multiple myeloma,” said Krishnan Viswanadhan, Senior Vice President, Global Cell Therapy Franchise Lead for Bristol Myers Squibb. “This amended partnership allows Bristol Myers Squibb to leverage our global manufacturing capabilities and consolidate all responsibilities outside the United States.”The companies will continue to equally share profits and losses in the U.S., Bluebird said. Furthermore, Bluebird...
On Saturday, Tesla filed a lawsuit against Alameda County for not allowing the company to restart operations at its factory based in Fremont, California, and CEO Elon Musk threatened to move Tesla’s headquarters to Nevada or Texas. By Monday, multiple reports emerged that employees were spotted at the factory, and that Tesla began making cars again. The Final Round panel discusses what’s next for the automaker. ...
